Francesco Costanzo Selected Research

ferlixit

1/2022

Iron Administration Overcomes Resistance to Erastin-Mediated Ferroptosis in Ovarian Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Costanzo Research Topics

Disease

15	Neoplasms (Cancer) 01/2021 - 03/2003
5	Breast Neoplasms (Breast Cancer) 11/2017 - 05/2005
3	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2016
2	Endometrial Neoplasms (Endometrial Cancer) 06/2017 - 05/2014
2	Melanoma (Melanoma, Malignant) 02/2014 - 12/2011
2	Carcinogenesis 10/2006 - 07/2006
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	COVID-19 01/2021
1	Disease Progression 01/2021
1	Ischemic Stroke 12/2020
1	Stroke (Strokes) 04/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Acute Erythroblastic Leukemia (Erythroleukemia) 01/2020
1	Leukemia 01/2020
1	Hemolysis 11/2019
1	Ovarian Epithelial Carcinoma 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2018
1	Pathologic Processes 11/2017
1	Carcinoma (Carcinomatosis) 11/2014
1	Squamous Cell Carcinoma of Head and Neck 11/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2014
1	Hypertrophy 10/2012
1	Cardiomegaly (Heart Hypertrophy) 10/2012
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 10/2012
1	Familial Hypertrophic Cardiomyopathy (Cardiomyopathy, Familial Hypertrophic) 10/2012
1	Chest Pain (Chest Pains) 01/2012
1	Cataract (Cataracts) 06/2009
1	Eye Diseases (Eye Disease) 06/2009
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 12/2008
1	Familial Breast Cancer 11/2008
1	Genomic Instability 07/2006
1	Fallopian Tube Neoplasms 03/2003

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2006
6	IronIBA 01/2022 - 12/2011
6	ApoferritinsIBA 01/2020 - 06/2009
5	Biomarkers (Surrogate Marker)IBA 01/2019 - 05/2014
5	Ferritins (Ferritin)IBA 12/2018 - 06/2009
3	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 09/2018
2	Troponin T (Troponin T1)IBA 11/2019 - 01/2012
2	MicroRNAs (MicroRNA)IBA 01/2019 - 11/2017
2	ProteomeIBA 12/2011 - 01/2007
2	BRCA1 ProteinIBA 01/2007 - 07/2006
1	ferlixitIBA 01/2022
1	erastinIBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2018
1	Caffeine (No Doz)FDA LinkGeneric 01/2016
1	methylxanthineIBA 01/2016
1	Tumor Biomarkers (Tumor Markers)IBA 11/2014
1	Small Interfering RNA (siRNA)IBA 02/2014
1	Myosins (Myosin)IBA 10/2012
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 10/2012
1	Biological ProductsIBA 12/2011
1	RNA (Ribonucleic Acid)IBA 12/2011
1	PeriostinIBA 11/2008
1	Folate Receptor 1IBA 01/2007
1	NucleotidesIBA 10/2006
1	Amino Acids FDA Link 07/2006
1	Antineoplastic Agents (Antineoplastics)IBA 05/2005
1	Vinorelbine (Navelbine)FDA LinkGeneric 05/2005
1	Docetaxel (Taxotere)FDA Link 05/2005
1	Taxoids (Taxanes)IBA 05/2005
1	PoisonsIBA 05/2005
1	RacivirIBA 03/2003

Therapy/Procedure

2	Thrombectomy 12/2020 - 04/2020
2	Drug Therapy (Chemotherapy) 01/2019 - 09/2018
1	Length of Stay 01/2021
1	Long-Term Care 01/2021
1	Catheters 12/2020
1	Therapeutics 01/2020